What type of study is this?

This is a Animal Study study (also classified as: In Vitro Study).

August 24, 2025CellsOpen Access

Neuroprotective Effects of Calpain Inhibition in Parkinson’s Disease: Insights from Cellular and Murine Models

View Full Paper

Ask AI

Bookmark

Authors

VZVandana ZamanMedical University of South Carolina AGAmy GathingsMedical University of South Carolina KDKelsey P. DrasitesMedical University of South Carolina

Discussion

Member takes

Implication

Study demonstrates calpain inhibition reduces neuroinflammation and improves neuronal survival in cellular and murine models of Parkinson's Disease, indicating therapeutic potential.

Key Points

Calpain inhibition significantly improves neuronal survival and reduces neuroinflammation in models of Parkinson's disease.
Treatment with calpeptin reduced pro-inflammatory cytokines by over 50% in LPS-treated BV2 microglial cells, decreasing reactive oxygen species.
Analysis employed cellular models and a murine model, focusing on calpain-2's role in immune modulation and neuroprotection.
Findings support calpain-2 inhibition as a promising therapeutic strategy for neuroinflammation and neurodegeneration.

Cite This Study

Zaman et al. (2025) studied this question.

synapsesocial.com/papers/68af5bc7ad7bf08b1eadff97 https://doi.org/10.3390/cells14171310

View Full Paper

Ask AI

Bookmark

Implication

Study demonstrates calpain inhibition reduces neuroinflammation and improves neuronal survival in cellular and murine models of Parkinson's Disease, indicating therapeutic potential.

Neuroprotective Effects of Calpain Inhibition in Parkinson’s Disease: Insights from Cellular and Murine Models

Discussion

Member takes

Implication

Key Points

Cite This Study

Neuroprotective Effects of Calpain Inhibition in Parkinson’s Disease: Insights from Cellular and Murine Models

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider